
    
      Study Objectives:

        -  To compare the safety profile and risk of hemolysis of ACZONE Gel, 5% to that of the
           vehicle after 12 weeks each of twice daily applications in acne vulgaris subjects with
           glucose-6-phosphate-dehydrogenase (G6PD) deficiency.

        -  To determine the systemic levels of plasma dapsone and N-acetyl dapsone during treatment
           with ACZONE Gel, 5%.

      Study Population:

      Approximately 60 male and female subjects

      Study Treatment:

      All subjects in the study will receive ACZONE Gel, 5% and vehicle in 1 of 2 sequences; each
      for a 12-week period.
    
  